Journal article
Serum Fructosamine and Subsequent Breast Cancer Risk: A Nested Case-Control Study in the ORDET Prospective Cohort Study
Abstract
There is evidence that abnormal glucose metabolism may contribute to the risk of breast cancer. The measurement of markers of glucose metabolism could help to identify women at risk for breast cancer. Serum fructosamine is one such marker. In this study, we investigated whether prediagnostic serum fructosamine was associated with breast cancer. Between 1987 and 1992, 10,786 women ages 35 to 69 were recruited in Italy for a prospective study. …
Authors
Platek M; Krogh V; Micheli A; Browne R; Meneghini E; Sieri S; Schünemann HJ; Pala V; Barba M; Wilding GE
Journal
Cancer Epidemiology Biomarkers & Prevention, Vol. 14, No. 1, pp. 271–274
Publisher
American Association for Cancer Research (AACR)
Publication Date
January 1, 2005
DOI
10.1158/1055-9965.271.14.1
ISSN
1055-9965